Pathstone Family Office’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$2.36M Buy
5,151
+2,575
+100% +$1.15M 0.02% 440
2023
Q2
$1.08M Buy
2,576
+200
+8% +$80.6K 0.02% 456
2023
Q1
$1.02M Sell
2,376
-10,968
-82% -$3.92M 0.02% 436
2022
Q4
$2.9M Buy
13,344
+4,098
+44% +$1.28M 0.02% 400
2022
Q3
$2.83M Buy
9,246
+6,932
+300% +$2.35M 0.03% 336
2022
Q2
$702K Buy
2,314
+387
+20% +$117K 0.02% 444
2022
Q1
$642K Sell
1,927
-122
-6% -$38.1K 0.02% 456
2021
Q4
$755K Buy
2,049
+128
+7% +$43.2K 0.02% 408
2021
Q3
$575K Buy
1,921
+772
+67% +$234K 0.02% 464
2021
Q2
$317K Buy
1,149
+1
+0.1% +$254 0.01% 624
2021
Q1
$284K Buy
+1,148
New +$292K 0.01% 497
2018
Q2
Sell
-26
Closed -$2K 306
2018
Q1
$2K Buy
+26
New +$2.28K ﹤0.01% 337
2017
Q2
Sell
-20
Closed -$1K 610
2017
Q1
$1K Buy
+20
New +$1.34K ﹤0.01% 515

Other funds holding SNPS

Pathstone Family Office's SNPS Position: Q3 2023 in Review

Pathstone Family Office increased its Synopsys (SNPS) stake by 100% in Q3 2023, buying an estimated $1.15M and bringing the position to 5,151 shares worth $2.36M. The position accounts for 0.02% of the portfolio, ranked #440.

Pathstone Family Office first reported a position in SNPS in Q1 2017 and has held it in 13 quarters since. The position peaked at $2.9M in Q4 2022. 1,037 funds tracked by Wall St. Rank hold SNPS as of Q3 2023.

  • Pathstone Family Office held 5,151 shares of Synopsys worth $2.36M as of Q3 2023.
  • Pathstone Family Office bought 2,575 Synopsys shares in Q3 2023, an estimated $1.15M.
  • Synopsys made up 0.02% of Pathstone Family Office's portfolio in Q3 2023, its #440 holding.
  • Pathstone Family Office first reported a position in Synopsys in Q1 2017 and has held it in 13 quarters since.
  • Pathstone Family Office's Synopsys position peaked at $2.9M in Q4 2022.
  • 1,037 funds tracked by Wall St. Rank held Synopsys as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.